The dynamic change of serum S100B levels from day 1 to day 3 is more associated with sepsis-associated encephalopathy
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
We investigated the role of dynamic changes of serum levels S100B protein in brain injury and poor outcome of sepsis. This is a prospective cohort study designed to include 104 adult patients with sepsis who are admitted to ICU from Jan 2015 to Aug 2016. Sepsis was defined as sepsis 3.0. Patients with a GCS score of <15, or at least one positive CAM-ICU score were thought to have brain dysfunction. 59 patients were diagnosed with SAE and the rest 45 patients were diagnosed with non-SAE. Serum S100B was measured on day 1 and 3 after ICU admission. Primary outcomes included brain dysfunction and 28-day/180-day mortality. The SAE group showed a significantly higher APACHE II score, SOFA scores, length of ICU stay, 28-day and 180-day mortality, serum S100B levels on day 1 and day 3. S100B levels on day 1 of 0.226 μg/L were diagnostic for SAE with 80.0% specificity and 66.1% sensitivity, and the area under (AUC) the curve was 0.728, S100B levels on day 3 of 0.144 μg/L were diagnostic for SAE with 84.44% specificity and 69.49% sensitivity, and the AUC was 0.819. In addition, the AUC for S100B on day 3 for predicting 180-day mortality was larger than for S100B on day 1 (0.731 vs. 0.611). Multiple logistic regression analysis showed that S100B3 (p = 0.001) but not S100B1 (p = 0.927) were independently correlated with SAE. Kaplan-Meier survival analysis showed that patients with S100B levels higher than 0.144 μg/L had a lower probability of survival at day 180. There were more patients with encephalopathy and a higher 28-day or 180-day mortality in the ΔS100B + group than in the ΔS100B- group. Multiple logistic regression analysis showed that SAE and IL-6 on day 3 were independently correlated with S100B dynamic increase. These findings suggest that elevated serum S100B levels on day 3 and the dynamic changes of serum S100B levels from day three to one were more associated with brain dysfunction and mortality than that on day 1 in patients with sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long-term cognitive impairment after critical illness
Pandharipande, P. P., Girard, T. D., Jackson, J. C., Morandi, A., Thompson, J. L., Pun, B. T., Brummel, N. E., Hughes, C. G., Vasilevskis, E. E., Shintani, A. K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301372 · Cited by 2,842
Sepsis-associated encephalopathy
Gofton, T. E., & Young, G. B. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.183 · Cited by 821
Potentially modifiable factors contributing to sepsis-associated encephalopathy
Sonneville, R., de Montmollin, E., Poujade, J., Garrouste-Orgeas, M., Souweine, B., Darmon, M., Mariotte, E., Argaud, L., Barbier, F., Goldgran-Toledano, D., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4807-z · Cited by 323
Brain Barrier Breakdown as a Cause and Consequence of Neuroinflammation in Sepsis
Danielski, L. G., Giustina, A. D., Badawy, M., Barichello, T., Quevedo, J., Dal-Pizzol, F., & Petronilho, F. (2018) · Molecular Neurobiology · doi:10.1007/s12035-016-0356-7 · Cited by 182
Characterization of Sepsis and Sepsis-Associated Encephalopathy
Feng, Q., Ai, Y.-H., Gong, H., Wu, L., Ai, M.-L., Deng, S.-Y., Huang, L., Peng, Q.-Y., & Zhang, L.-N. (2019) · Journal of Intensive Care Medicine · doi:10.1177/0885066617719750 · Cited by 101
Self-citationEndotoxemia-induced inflammation and the effect on the human brain
van den Boogaard, M., Ramakers, B. P., van Alfen, N., van der Werf, S. P., Fick, W. F., Hoedemaekers, C. W., Verbeek, M. M., Schoonhoven, L., van der Hoeven, J. G., & Pickkers, P. (2010) · Critical Care · doi:10.1186/cc9001 · Cited by 84
Research works printed but not linked: 41
- Singer, M. et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315, 801–810 (2016). · DOI · Paper page
- Zhang, L. N. et al. Epidemiological features and risk factors of sepsis-associated encephalopathy in intensive care unit patients: 2008-2011. Chin Med J (Engl) 125, 828–831 (2012).
- Schuler, A. et al. The Impact of Acute Organ Dysfunction on Long-Term Survival in Sepsis. Crit Care Med 46, 843–849 (2018). · DOI · Paper page
- Eidelman, L. A., Putterman, D., Putterman, C. & Sprung, C. L. The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities. JAMA 275, 470–473 (1996).
- Sharshar, T., Bozza, F. & Chrétien, F. Neuropathological processes in sepsis. Lancet Neurol 13, 534–536 (2014). · DOI
- Mazeraud, A. et al. Neuroanatomy and Physiology of Brain Dysfunction in Sepsis. Clin Chest Med 37, 333–345 (2016). · DOI
- Sweis, R., Ortiz, J. & Biller, J. Neurology of Sepsis. Curr Neurol Neurosci Rep 16, 21 (2016). · DOI
- Hughes, C. G. et al. Endothelial Activation and Blood-Brain Barrier Injury as Risk Factors for Delirium in Critically Ill Patients. Crit Care Med 44, e809–817 (2016). · DOI
- Davies, D. C. Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J Anat 200, 639–646 (2002). · DOI · Paper page
- Sharshar, T., Polito, A., Checinski, A. & Stevens, R. D. Septic-associated encephalopathy–everything starts at a microlevel. Crit Care 14, 199 (2010). · DOI · Paper page
- Jensen, R., Marshak, D. R., Anderson, C., Lukas, T. J. & Watterson, D. M. Characterization of human brain S100 protein fraction: amino acid sequence of S100 beta. J Neurochem 45, 700–705 (1985). · DOI
- Bloomfield, S. M., McKinney, J., Smith, L. & Brisman, J. Reliability of S100B in predicting severity of central nervous system injury. Neurocrit Care 6, 121–138 (2007). · DOI · Paper page
- Thelin, E. P., Nelson, D. W. & Bellander, B. M. A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury. Acta Neurochir (Wien) 159, 209–225 (2017). · DOI · Paper page
- Monbailliu, T., Goossens, J. & Hachimi-Idrissi, S. Blood protein biomarkers as diagnostic tool for ischemic stroke: a systematic review. Biomark Med 11, 503–512 (2017). · DOI
- Derwall, M., Stoppe, C., Brücken, D., Rossaint, R. & Fries, M. Changes in S-100 protein serum levels in survivors of out-of-hospital cardiac arrest treated with mild therapeutic hypothermia: a prospective, observational study. Crit Care 13, R58 (2009). · doi:10.1186/cc7785
- Al Tmimi, L. et al. Serum protein S100 as marker of postoperative delirium after off-pump coronary artery bypass surgery: secondary analysis of two prospective randomized controlled trials. Clin Chem Lab Med 54, 1671–1680 (2016). · DOI
- Nguyen, D. N. et al. Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock. Crit Care Med 34, 1967–1974 (2006). · DOI · Paper page
- Hamed, S. A., Hamed, E. A. & Abdella, M. M. Septic encephalopathy: relationship to serum and cerebrospinal fluid levels of adhesion molecules, lipid peroxides and S-100B protein. Neuropediatrics 40, 66–72 (2009). · DOI · Paper page
- Nguyen, D. N. et al. Serum S100B protein could help to detect cerebral complications associated with extracorporeal membrane oxygenation (ECMO). Neurocrit Care 20, 367–374 (2014). · doi:10.1007/s12028-013-9874-6
- Weigand, M. A. et al. Neuron-specific enolase as a marker of fatal outcome in patients with severe sepsis or septic shock. Anesthesiology 92, 905–907 (2000). · doi:10.1097/00000542-200003000-00057
- Anderson, B. J. et al. Admission plasma levels of the neuronal injury marker neuron-specific enolase are associated with mortality and delirium in sepsis. J Crit Care 36, 18–23 (2016). · DOI
- Piazza, O., Russo, E., Cotena, S., Esposito, G. & Tufano, R. Elevated S100B levels do not correlate with the severity of encephalopathy during sepsis. Br J Anaesth 99, 518–521 (2007). · DOI
- Yao, B., Zhang, L. N., Ai, Y. H., Liu, Z. Y. & Huang, L. Serum S100β is a better biomarker than neuron-specific enolase for sepsis-associated encephalopathy and determining its prognosis: a prospective and observational study. Neurochem Res 39, 1263–1269 (2014). · DOI
- Panni, J. K. & Panni, M. K. Changes in S100B levels rather than absolute values may be a better marker of severity of septic encephalopathy. Br J Anaesth 100, 419; author reply 419-420 (2008). · doi:10.1093/bja/aen009
- Nguyen, D. N. et al. Cortisol is an associated-risk factor of brain dysfunction in patients with severe sepsis and septic shock. Biomed Res Int 2014, 712742 (2014).
- Ehler, J. et al. Diagnostic value of NT-proCNP compared to NSE and S100B in cerebrospinal fluid and plasma of patients with sepsis-associated encephalopathy. Neurosci Lett 692, 167–173 (2019). · DOI · Paper page
- Zenaide, P. V. & Gusmao-Flores, D. Biomarkers in septic encephalopathy: a systematic review of clinical studies. Rev Bras Ter Intensiva 25, 56–62 (2013). · DOI
- Pfister, D. et al. Cerebral perfusion in sepsis-associated delirium. Crit Care 12, R63 (2008). · DOI · Paper page
- Pfister, D. et al. Intracranial pressure in patients with sepsis. Acta Neurochir Suppl 102, 71–75 (2008). · doi:10.1007/978-3-211-85578-2_14
- Hsu, A. A. et al. Neurological injury markers in children with septic shock. Pediatr Crit Care Med 9, 245–251 (2008). · DOI
- Jorge-Ripper, C. et al. Prognostic value of acute delirium recovery in older adults. Geriatr Gerontol Int 17, 1161–1167 (2017). · DOI
- Ercole, A., Thelin, E. P., Holst, A., Bellander, B. M. & Nelson, D. W. Kinetic modelling of serum S100b after traumatic brain injury. BMC Neurol 16, 93 (2016). · DOI
- Thelin, E. P., Nelson, D. W. & Bellander, B. M. Secondary peaks of S100B in serum relate to subsequent radiological pathology in traumatic brain injury. Neurocrit Care 20, 217–229 (2014). · DOI
- Lipcsey, M. et al. The brain is a source of S100B increase during endotoxemia in the pig. Anesth Analg 110, 174–180 (2010). · doi:10.1213/ane.0b013e3181c0724a
- Zhang, L. N. et al. Diagnostic and Predictive Levels of Calcium-binding Protein A8 and Tumor Necrosis Factor Receptor-associated Factor 6 in Sepsis-associated Encephalopathy: A Prospective Observational Study. Chin Med J (Engl) 129, 1674–1681 (2016). · DOI
- Heming, N. et al. Neuroanatomy of sepsis-associated encephalopathy. Crit Care 21, 65 (2017). · DOI · Paper page
- Kapural, M. et al. Serum S-100beta as a possible marker of blood-brain barrier disruption. Brain Res 940, 102–104 (2002). · DOI · Paper page
- Rosén, H., Sunnerhagen, K. S., Herlitz, J., Blomstrand, C. & Rosengren, L. Serum levels of the brain-derived proteins S-100 and NSE predict long-term outcome after cardiac arrest. Resuscitation 49, 183–191 (2001). · DOI
- Hasselblatt, M. et al. Serum S100beta increases in marathon runners reflect extracranial release rather than glial damage. Neurology 62, 1634–1636 (2004). · DOI
- Yende, S. et al. Long-Term Quality of Life Among Survivors of Severe Sepsis: Analyses of Two International Trials. Crit Care Med 44, 1461–1467 (2016). · DOI · Paper page
- Hughes, C. G. et al. Relationships between markers of neurologic and endothelial injury during critical illness and long-term cognitive impairment and disability. Intensive Care Med 44, 345–355 (2018). · DOI
Cited by
Hou, N., Li, M., He, L., Xie, B., Wang, L., Zhang, R., Yu, Y., Sun, X., Pan, Z., & Wang, K. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02620-5 · Cited by 568
Biomarkers for sepsis: more than just fever and leukocytosis—a narrative review
Barichello, T., Generoso, J. S., Singer, M., & Dal-Pizzol, F. (2022) · Critical Care · doi:10.1186/s13054-021-03862-5 · Cited by 462
Cerebral dysfunctions caused by sepsis during ageing
Manabe, T., & Heneka, M. T. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00643-7 · Cited by 191
Characterization of Sepsis and Sepsis-Associated Encephalopathy
Feng, Q., Ai, Y.-H., Gong, H., Wu, L., Ai, M.-L., Deng, S.-Y., Huang, L., Peng, Q.-Y., & Zhang, L.-N. (2019) · Journal of Intensive Care Medicine · doi:10.1177/0885066617719750 · Cited by 101
Self-citationLi, Z., Zhang, F., Sun, M., Liu, J., Zhao, L., Liu, S., Li, S., & Wang, B. (2023) · PeerJ · doi:10.7717/peerj.15122 · Cited by 43
“Patients with delirium after sepsis and other conditions showed higher IL-6 and IL-8 levels than cognitively healthy patients ( Wu et al., 2020 ; De Rooij et al., 2007 ; Van Munster et al., 2008 ), indicating that cytokine-induced toxicity in the brain can worsen cognitive function in septic…”
Metadata
- Authors
- Wu, L., Feng, Q., Ai, M.-L., Deng, S.-Y., Liu, Z.-Y., Huang, L., Ai, Y.-H., & Zhang, L.
- Venue
- Scientific Reports
- Published
- 2020-05-07
- Volume
- 10
- Issue
- 1
- Pages
- 7718-7718
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W3022376850
- Cited by
- 56
- References
- 6
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Funders
- National Natural Science Foundation of China (81401099)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The dynamic change of serum S100B levels from day 1 to day 3 is more associated with sepsis-associated encephalopathy. https://app.cochat.ai/papers/10.1038/s41598-020-64200-3
- The paper
- Wu, L., Feng, Q., Ai, M.-L., Deng, S.-Y., Liu, Z.-Y., Huang, L., Ai, Y.-H., & Zhang, L. (2020). The dynamic change of serum S100B levels from day 1 to day 3 is more associated with sepsis-associated encephalopathy. Scientific Reports. https://doi.org/10.1038/s41598-020-64200-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.